Efficacy of Pain Monitor, a Smartphone App for Chronic Pain
Pain Monitor: a Randomized Controlled Trial to Test the Efficacy of a Pain App in the Treatment of Chronic Pain
1 other identifier
interventional
150
1 country
1
Brief Summary
The present investigation aims at exploring the effect of including a pain app called Pain Monitor for chronic pain patients' daily monitoring. Three conditions will be set:
- 1.usual treatment (waiting list)
- 2.usual treatment + app (without alarms)
- 3.usual treatment + app (with alarms)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Sep 2017
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
August 14, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2018
CompletedMay 17, 2018
May 1, 2018
7 months
July 25, 2017
May 16, 2018
Conditions
Outcome Measures
Primary Outcomes (4)
Change in pain intensity
A numerical rating scale (0-10 range) will be used.
Dialy during 30 days (app condition) in the app condition (with and without alarm)
Change in side effects
A list of the most frequent side effects of pain medication was created
Dialy during 30 days (app condition) in the app condition (with and without alarm)
Change in pain intensity
A numerical rating scale (0-10 range) will be used.
Twice (first day of study and 30 days after, at the end of study) in the TAU condition
Change in side effects
A list of the most frequent side effects of pain medication was created
Twice (first day of study and 30 days after, at the end of study) in the TAU condition
Secondary Outcomes (14)
Change in mood
Dialy during 30 days (app condition) in the app condition (with and without alarm)
Change in mood
Twice (first day of study and 30 days after, at the end of study) in the TAU condition
Change in rescue medication use
Dialy during 30 days (app condition) in the app condition (with and without alarm)
Change in rescue medication use
Twice (first day of study and 30 days after, at the end of study) in the TAU condition
Change in pain interference
Dialy during 30 days (app condition) in the app condition (with and without alarm)
- +9 more secondary outcomes
Study Arms (3)
Treatment as usual (waiting list)
ACTIVE COMPARATORPatients at this condition will receive the usual medical treatment at the pain unit, but they will not be monitored daily using the app.
Treatment as usual + app (without alarm)
EXPERIMENTALParticipants at this condition will receive the usual medical treatment for their pain but also they will be monitored daily using the Pain Monitor app. Because alarms will not be generated, physicians will not know if an undesired event is occuring despite the app is actually collecting data.
Treatment as usual + app (with alarm)
EXPERIMENTALParticipants at this condition will receive the usual medical treatment for their pain but also they will be monitored daily using the Pain Monitor app. Alarms will be generated in the face of certain preestablished events. Physicians will be asked to call patients and change/stop treatment if an alarm is received.
Interventions
Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.
Patients will be offered the usual treatment for their pain, which is not changed by study participation
Eligibility Criteria
You may qualify if:
- The patient is over 18 years of age
- The patient has a mobile phone with Android operating system
- The patient has the physical ability to use the application
- The patient does not present psychological and / or cognitive alterations or problems with language that make their participation difficult
- The patient voluntarily wants to participate and signs the informed consent
You may not qualify if:
- The patient is under 18 years
- The patient does not have a mobile phone or has a mobile phone in which Android is not the operating system (the app is currently only available for Android for economic reasons)
- The patient does not have the physical capacity to use the application
- The patient does not have the capacity to participate due to psychological and / or cognitive alterations or problems with language
- The patient does not want to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vall d'Hebron Hospital
Barcelona, 08035, Spain
Related Publications (2)
Rosser BA, Eccleston C. Smartphone applications for pain management. J Telemed Telecare. 2011;17(6):308-12. doi: 10.1258/jtt.2011.101102. Epub 2011 Aug 15.
PMID: 21844177BACKGROUNDSuso-Ribera C, Mesas A, Medel J, Server A, Marquez E, Castilla D, Zaragoza I, Garcia-Palacios A. Improving pain treatment with a smartphone app: study protocol for a randomized controlled trial. Trials. 2018 Feb 27;19(1):145. doi: 10.1186/s13063-018-2539-1.
PMID: 29482614DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ángela Mesas Idáñez, MD
Staff Doctor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Patients will be informed of the condition they have been assigned to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 25, 2017
First Posted
August 14, 2017
Study Start
September 1, 2017
Primary Completion
March 30, 2018
Study Completion
April 30, 2018
Last Updated
May 17, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share
Only the two principal investigators, Dr. Mesas and Dr. Suso, will be able to access to individual participant data.